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Background: Norovirus is one of the most common causes of nonbacterial gastroenteritis in humans. Rapid
spread by contaminated food and person-to-person transmission through the fecal-oral route are characteristics of
norovirus epidemiology and result in high morbidity in vulnerable patient populations. Therefore, detection of
norovirus is a major public health concern. Currently, the most common method for detecting and differentiating
among norovirus strains in clinical and environmental samples is reverse transcription PCR (RT-PCR). Standardized
positive controls used in RT-PCR assays to detect norovirus are designed to overcome the problem of false-
negative results due to PCR inhibitors and suboptimal reaction conditions.
Results: In the current study, four types of RNA transcripts were produced from plasmids: norovirus GI-5 and GII-4
capsid regions with human rotavirus (VP7 gene derived) fragment insertions, and norovirus GI-6 and GII-4 capsid
regions with hepatitis A virus (VP1/P2A gene derived) fragment insertions. These size-distinguishable products were
used as positive controls under the RT-PCR assay conditions used to detect NoV in stool and groundwater samples.
Their reliability and reproducibility was confirmed by multiple sets of experiments.
Conclusions: These standardized products may contribute to the reliable and accurate diagnosis by RT-PCR of
norovirus outbreaks, when conducted by laboratories located in different regions.
Background
Gastroenteritis, also known as “stomach flu”,i sam a j o r
public health concern and causes over 1.8 million deaths
worldwide every year in children younger than five. Sev-
eral studies and diagnostic analyses have shown that
noroviruses (NoVs) are the leading cause of acute non-
bacterial gastroenteritis. Although the gastroenteritis
caused by NoVs is mild and of short duration, it affects
persons of all ages and sometimes leads to death.
Although severe illness is rare, complications related to
dehydration can occur in very young and elderly indivi-
duals, and those with weakened immune systems.
Depending on whether the dehydration is treated
promptly, patients in these groups may face life-threa-
tening risks. Therefore, the detection and monitoring of
NoV is an important task for national public health
agencies [1,2].
Norovirus is a member of the Caliciviridae family and
has been classified into five genogroups (GI to GV)
based on capsid gene sequence homology. The positive-
sense, single-stranded RNA genome sized 7.6 kb con-
tains three open reading frames (ORFs) [3,4]. The NoVs
that are the most common causative agents of human
infection are in the GI and GII genogroups; each of
these genogroups is further divided into 8 and 17 geno-
types, respectively [4-6].
When sensitive diagnostic methods first became avail-
able, the pathogenic importance of norovirus was not
yet known. Since 1972, when NoV was first discovered
by immuno-electron microscopic examination of stool
samples, several methods for the detection of NoV have
been developed [7,8]. Once the sequence of NoV was
available, RT-PCR methods of detection were developed.
Because current RT-PCR methods are sensitive and spe-
cific enough to detect low levels of a broad spectrum of
viruses from samples, RT-PCR is an invaluable tool for
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detection of viruses is usually the RNA polymerase
gene, which is conserved among the NoVs. Of the cur-
rently available assays for viral detection (electron
microscopy, immuno-electron microscopy, serology, and
RT-PCR), RT-PCR assay of stool samples is the most
widely used clinical detection method.
Although RT-PCR is potentially a fast and reliable
method of detecting and typing NoV, it has some draw-
backs, such as the possibility of false-negative or -posi-
tive results [9]. In the present study, to address the issue
of false-negative results and to confirm NoV detection,
standard positive-control products that were different in
size from the RT-PCR product of the NoV target region
were designed. These positive controls were then used
in RT-PCR under the same conditions as actual clinical
and environmental samples.
Methods
Viral RNA preparation and RT-PCR reaction
Stool samples from patients with viral diarrhea (col-
l e c t e da n dp r o v i d e db yC h u n g n a mU n i v e r s i t yH o s p i t a l
in 2006 and Changwon Fatima Hospital in 2005) from
the Waterborne Virus Bank were used for NoV viral
RNA preparation. Samples from Keimyung University
Dongsan Hospital and from Chungbuk National Univer-
sity Hospital in 2009 were used for the preparation of
viral RNA from human rotavirus (HRV) and hepatitis A
virus (HAV), respectively.
One gram of each stool sample was suspended in 9 ml
of Dulbecco’s phosphate buffered saline, and 140 μlo f
the suspended sample applied to the QIAmp Viral RNA
Mini kit (QIAGEN), in accordance with the manufac-
turer’s instructions.
The viral RNA was eluted with 60 μl of diethyl pyro-
carbonate-treated water and then used as the template
for RT-PCR. RT-PCR was conducted with the One-Step
RT-PCR PreMix kit (iNtRON Biotechnology, Korea)
according to the manufacturer’si n s t r u c t i o n s .B r i e f l y ,5
μl of each viral template RNA was mixed with 1 μl( 2 0
pmol) of each of the One-step RT-PCR primers (Table
1), 13 μl of water, and One-step RT-PCR PreMix. The
reverse transcription reaction took place at 45°C for 30
min, followed by RNA denaturation at 94°C for 5 min
and then 30 cycles of denaturation (94°C for 30 s),
annealing (NoV, 55°C for 60 s; HRV, 60°C for 60 s; and
HAV, 65°C for 60 s), extension (72°C for 1 min), and
final extension (72°C for 5 min), with a Px2 thermal
cycler (Thermo Fisher Scientific, USA).
The RT-PCR products were analyzed by electophor-
esis on a 2% agarose gel and then cloned into the
pGEM-T Easy Vector (Promega, USA). Plasmid trans-
formation of E. coli DH5a was then confirmed by
sequencing (Cosmo Genetech, Korea).
Viral gene manipulation and plasmid construction
Plasmid DNA was prepared from transformed E. coli
DH5 a with a plasmid DNA mini kit (Real biotech, Tai-
wan). pGEM-T Easy Vector plasmids containing the
NoV fragment (which has a single NarI restriction site
in the middle of capsid region) were digested with the
restriction enzyme NarI (Roche Applied Science, Ger-
many) and then treated with alkaline phosphatase
(Roche Applied Science, Germany). Plasmids containing
HRV (VP7 gene derived) or HAV (VP1/P2A gene
derived) gene fragments that were cloned with primer
sets designed to add NarI recognition sites were also
incubated with NarI. The digested HRV and HAV frag-
ments were then purified with a Gel/PCR DNA Mini kit
(Real Biotech, Taiwan) from 2% agarose gels. The puri-
fied fragments were ligated into the NarI-digested NoV
plasmids using a DNA ligation kit (TaKaRa, Japan) and
transformed into E. coli DH5a. Successful transforma-
tion was then confirmed by sequencing (Cosmo Gene-
tech, Korea).
In vitro RNA transcription
To produce RNA transcripts under the T7 promoter,
plasmids were linearized with the restriction enzyme
SpeI (Roche applied Science, Germany) and transcribed
with the MAX large-scale RNA production system with
T7 polymerase (Promega, USA). RNA transcripts were
then purified with the RNA Cleanup kit (QIAGEN,
Germany).
Application to clinical and environmental samples
Stool samples and environmental sample obtained from
the Waterborne Virus Bank were used for NoV viral
RNA preparation. Viral RNA was extracted using
QIAmp Viral RNA Mini kit (QIAGEN, Germany), in
accordance with the manufacturer’s instructions. To
confirm size-distinguishable products, RT-PCR was con-
ducted with a One-Step RT PCR PreMix kit (iNtRON
Biotechnology, Korea). RT-PCR and semi-nested PCR
amplication were applied with primer sets (Table 1). We
used 5 μl of viral RNA or RNA transcripts as the tem-
plate and 15 μl of the premixed kit solution. The PCR
was carried out in a PCR System Px2 thermal cycler
(Thermo Hybaid, Middlesex, United Kingdom) accord-
ing to the following protocol: one initial RT step at 45°C
for 30 min, followed by PCR activation at 94°C for 5
min; followed by 30 cycles of amplification at 30 s at 94°
C, 60 s at 55°C and 65°C, and 1 min at 72°C; with a final
extension step of 10 min at 72°C. In the case of environ-
mental sample, 2 μl of products from this reaction was
used for the templates in the semi-nested PCR with 18
μl of PCR PreMix (iNtRON Biotechnology, Korea) and
the primer sets (NV-GIF2/NV-GIRIM for NoV GI; NV
GIIF3M/NV-GIIR1M for NoV GII; HAV-2F/HAV-2R
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C for 5 min; followed by 25 cycles of amplification at 30
s at 94°C, 30 s at 55°C and 65°C, and 90 s at 72°C; with
a final extension step of 10 min at 72°C. The PCR pro-
ducts were run on 1.5% agarose gels, stained with ethi-
dium bromide, and visualized under UV light. The
products were extracted from the agarose gel with a
QiaQuick PCR purification kit (QIAGEN, Germany),
and the sequences were analyzed by Cosmogenetech
(Seoul, South Korea).
Results
Cloning of RT-PCR amplified NoV, HRV, and HAV genes
Viral RNA extracted from the stool samples of patient
hospitalized from viral diarrhea was used as the tem-
plate for RT-PCR. The amplified RT-PCR products were
then analyzed by 2% agarose gel electrophoresis. The
NoV capsid regions GI and GII were 330 bp and 341
bp, respectively. Sequencing analysis of the cloned RT-
PCR products indicated that the NoV genotypes were
GI-5, GI-6, and GII-4 (Figure 1A, B, and 1C). These
three NoV capsid genotypes were cloned into the
pGEM-T Easy Vector, and the resulting plasmids were
used as backbones for the construction of standardized
positive control plasmids.
To create size-distinguishab l ep r o d u c t s ,t h eV P 7a n d
VP1/P2A regions of HRV and HAV, respectively, were
amplified with primer sets designed to contain NarI
recognition sites and then inserted into pGEM-T Easy
Vectors for further manipulation. The RT-PCR products
of HRV and HAV from the stool samples had the
expected size of 375 bp and 612 bp, respectively (Figure
1 Da n d1 E ) .T h ev i r u sf r o mw h i c ht h eH R Vf r a g m e n t s
originated was classified as the G4[P6] genotype by
sequencing.
Confrimation of standardized positive-control plasmids
containing cloned viral gene
As shown in Figure 2, cloned NoV capsid gene-containing
plasmids were digested with NarI and then treated with
alkaline phosphatase prior to ligation with the HAV and
HRV gene fragment RT-PCR products. The four resulting
plasmid types contained 705, 716, 936, or 947 bp NoV-
plus-insert fragments, as confirmed by sequencing.
Confirmation of size-distinguishable standardized
positive-control
To determine whether they were suitable as positive
controls, the RNA transcripts were used as templates in
RT-PCR under the same conditions used for environ-
mental and clinical samples. When RT-PCR to detect
NoV was performed, the positive control reactions
yielded transcripts of the expected size.
The First, For the detection of NoV in environmental
sample, RT-PCR amplication was carried out with size-
distinguishable standardized positive-control, NoV posi-
tive stool samples (Genogroup I and II), and D.W as
negative control. Two NoV Positive sample were
detected as shown by the 313 bp and the 310 bp ampli-
fied band (Figure 3(A), lane 4 and Figure 3(B), lane 1).
In addition, it was observed that the 689 bp and the 686
bp size-distinguishable standardized positive-control
amplified band was detected (Figure 3(A), lane 2 and
Figure 3(B), lane 1). Negative control was not detected.
The Second, for the detection of NoV in stool sample,
was carried out with size-distinguishable standardized
positive-control, NoV positive stool samples (Genogroup I
and II), and D.W as negative control. Two NoV Positive
sample were detected as shown by the 330 bp and the 341
bp amplified band (Figure 3(C), lane 4 and Figure 3(D),
lane 5). In addition, it was observed that the 936 bp and
Table 1 Primer sets used to clone NoV capsid regions, HRV VP7, and HAV VP1/P2A
Virus, region Primers and Sequences (5’®3’) Location Application
NoV GI Capsid GI-FIM; CTGCCCGAATTYGTAAATGATGAT 5342-5365
a Onestep RT-PCR
GI-RIM; CCAACCCARCCATTRTACATYTG 5649-5671
a Onestep RT-PCR and Semi-nested PCR
GI-F2; ATGATGATGGCGTCTAAGGACGC 5358-5380
a Seminested PCR
NoV GII Capsid GII-FIM; GGGAGGGCGATCGCAATCT 5049-5067
b Onestep RT-PCR
GII-RIM; CCRCCIGCATRICCRTTRTACAT 5367-5389
b Onestep RT-PCR and Semi-nested PCR
GII-F3M; TTGTGAATGAAGATGGCGTCGART 5079-5102
b Semi-nested PCR












aGenBank accession number M87661.
bGenBank accession number X86557.
cGenBank accession number HQ392461.
dGenBank accession number AF268396.
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trol amplified band was detected (Figure 3(C), lane 2 and
Figure 3(D), lane 1). Negative control was not detected.
Detection of HRV and HAV in clinical and environmental
samples
For the detection of HRV in clinical sample, RT-PCR
amplification was carried out with standardized positive-
control, HRV positive stool sample, and D.W as negative
control. All of both standardized positive-control and
HRV positive sample and were detected as shown by
the 375 bp amplified band (Figure 4(A), lane 1 and 2).
In addition, Negative control was not detected.
For the detection of HAV in environmental sample,
RT-PCR amplification was carried out with standardized
positive-control, HAV positive stool sample, and D.W as
negative control. All of both standardized positive-con-
trol and HAV positive sample and were detected as
shown by the 413 bp amplified band (Figure 4(A), lane
1 and 2). In addition, Negative control was not detected.
Discussion
The primary cause of acute nonbacterial gastroenteritis,
NoV causes symptoms such as acute diarrhea, headache,
abdominal pain, vomiting, nausea, fatigue, and low-grade
fever. These symptoms usually develop 24-48 h after
exposure. NoV spread by the fecal-oral route after expo-
sure to contaminated food or water is the main source of
outbreaks of acute gastroenteritis [10-12]. NoV has sev-
eral characteristics that facilitate its spread [13]: (1) The
infectious dose is very low (approximately 18-1,000 viral
particles), which allows it to spread via several routes,
including droplets, person-to-person contact, and
fomites, as well as environmental contamination. The
low infectious dose is also reflected in the high secondary
attack rates (>30%) resulting from contact with an
infected individual. (2) Prolonged periods of shedding of
NoV particles increases the secondary spread (3) It is
stable in a wide range of temperatures (from 0° to 60°C)
and under various environmental conditions (such as
those found in recreational and drinking water and a
variety of food items, including raw oysters, fruits, and
vegetables). (4) There are many NoV strains, which
means that individuals may be infected multiple times,
because of incomplete cross protection and no long-term
immunity. (5) Mutations occur frequently, leading to
antigenic shift, and recombination creates new strains
that are capable of infecting susceptible hosts.
Figure 1 Transcripts of targeted viral genes produced by RT-PCR prior to insertion into plasmids. Capsid regions of NoV GI-5 (A), NoV GI-
6 (B), NoV GII-4 (C), HRV VP7 (D), and HAV VP1/P2A (E). Lane 1, 100 bp ladder; lane 2, negative controls; lane 3, positive results.
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the development of fast and sensitive methods to detect
and differentiate among strains of NoV has been a
major public health issue in South Korea, as in other
countries [14,15]. A variety of enzyme immunoassay
(EIA) detection kits have been produced, but they have
limitations with regard to specificity and sensitivity.
Some are highly specific for certain NoV strains, but
they are not sensitive enough to detect a wide range of
NoV strains. Furthermore, the presence of virus-specific
IgM antibodies in adult sera can make it difficult to
interpret the results of EIA kits [16]. Serological assays
also have diagnostic limitations; after exposure, several
days may elapse before IgM antibody levels are high
enough to be detected. In addition, it is not possible to
culture human NoV, further limiting available detection
methods.
RT-PCR is a technique that is widely used in research
and clinical diagnosis. However, many researchers have
expressed concern about the risk of false-positive and
-negative results. Viral RNA extracted from stool sample
has been used as the control for RT-PCR assays for the
detection of NoV in South Korea. But it has the pro-
blem such as false positive by cross-contamination.
False-positive results can be avoided, to a large extent,
by taking measures to avoid contamination and by
employing multiple negative controls.
To overcome another problem, false-negative results,
caused by polymerase-inhibiting substances, incorrect
PCR mixes, or defective thermal cyclers, positive con-
trols are required [17]. To date, several internal stan-
dards prepared and used for NoV have shown some
limitation, such as the difficul t yt od i s t i n g u i s ht h ec o n -
trol by gel electrophoresis. And nested PCR is currently
the most sensitive diagnostic assay for the low concen-
tration of NoV in environmental samples, but the con-
trol for nested PCR assay to detect NoV had been not
available.
To solve those problems above, we designed and con-
structed internal standards. As reported on the previous
Figure 2 Strategy to produce standardized positive-control plasmids containing cloned viral genes. The four types of resulting plasmids
were used to produce RNA transcripts. (A) NoV GI-5 + HRV and NoV GII-4 + HRV, (B) NoV GI-6 + HAV and NoV GII-4 + HAV.
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Korea [18], GII-4 is the most prevalent genotype (71.9%)
and GI-6 is another important genotype for is second pre-
valence and majority among the GI genogroup. And GI-5
was reported as one of emerging genotype on the Korean
groundwater sample inspection. So, the PCR positive con-
trols targeted these three genotypes, GII-4, GI-6, and GI-5,
are meaningful and practical to detect and confirm the
prevalent NoV genotypes with specificity and applicability
on the environmental and clinical samples.
And the two kinds of fragments, partial VP7 of HRV
and VP1/P2A region of HAV were inserted not only for
the distinguished size of PCR products, but also for the
detection and determination of genotype of another
main causing virus of acute gastroenteritis, HRV, as well
as the detection of one of main infectious disease caus-
ing virus, HAV [19,20].
The standardized positive-control plasmids described
herein produced transcripts of the distinguished size
when they were used as templates for RT-PCR under
the same conditions as environmental and clinical sam-
ples. And they showed have the advantage to overcome
false-negative results of stool sample analysis due to
inhibitory substances.
Thus, they are potentially a powerful means of con-
firming the presence or absence of NoV infection, and
may be helpful when establishing standard operating
procedures to face suspected epidemics. Furthermore,
these standardized positive controls can be used as con-
trols for RT-PCR assays to detect the epidemiologically
Figure 3 Confirmation of size-distinguishable standardized positive controls under the same RT-PCR conditions as clinical and
environmental samples. (A) NoV GI-5 + HRV and environmental sample: lane 1, 100 bp ladder; lane 2, standardized positive control; lane 3,
negative control; lane 4, environmental sample. (B) NoV GII-4 + HRV and environmental sample: lane 1, standardized positive control; lane 2, 100
bp ladder; lane 3, negative control; lane 4, negative control; lane 5, environmental sample. (C) NoV GI-6 + HAV and clinical sample: lane 1, 100
bp ladder; lane 2, standardized positive control; lane 3, negative control; lane 4, clinical sample. (D) NoV GII-4 + HAV with clinical sample: lane 1,
standardized positive control; lane 2, negative control; lane 3, 100 bp ladder; lane 4, negative control; lane 5, clinical sample.
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greater utility to public health researchers.
Conclusions
In the current study, four types of RNA transcripts were
produced from plasmids: NoV GI-5 and GII-4 capsid
regions with human rotavirus (HRV) fragment inser-
tions, and NoV GI-6 and GII-4 capsid regions with
hepatitis A virus (HAV) fragment insertions.
These size-distinguishable products were used as posi-
tive controls under the RT-PCR assay conditions used
to detect NoV in stool and groundwater samples. Their
reliability and reproducibility was confirmed by multiple
sets of experiments.
These standardized products may contribute to the
reliable and accurate diagnosis by RT-PCR of NoV out-
breaks, when conducted by laboratories located in differ-
ent regions.
These size-distinguishable products were applied to
nationwide survey a so-called “Research on the contami-
nation levels of norovirus in food catering facilities”
funded by Korea Food and Drug Administration
(KFDA) in 2010. And the result of size-distinguishable
products revealed the successful construction of internal
standards without the false-positive and -negative issue.
List of Abbreviations
HRV: Human rotavirus; HAV: Hepatitis A virus; NoVs: Norovirus; ORFs: Open
reading frames;
Acknowledgements
This work was supported by Mid-career Researcher Program (2008-0061575)
and Basic Science Research Program (2009-0062720) through NRF grant
funded by the MEST.
Author details
1Department of Microbiology, College of Medicine, The Catholic University
of Korea, Seoul 137-701, Republic of Korea.
2Department of Agricultural
Biology, National Academy of Agricultural Science, Rural Development
Association, Suwon, 441-707, Republic of Korea.
3Environmental Infrastructure
Research Department, National Institute of Environmental Research, Incheon
404-170, Republic of Korea.
Authors’ contributions
SGL and SHL made substantial contributions to the study design,
participated in data acquisition, analysis and interpretation and drafted and
revised the manuscript critically. CIS and SWP designed and conducted the
experiments. WHJ and SHO designed and conducted the experiments. SYP
made substantial contributions to conception and design of the experiment
and in revising the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 7 April 2011 Accepted: 26 May 2011 Published: 26 May 2011
References
1. Blacklow NR, Dolin R, Fedson DS, DuPont H, Northrup RS, Hornick RB,
Chanock RM: Acute infectious nonbacterial gastro-enteritis: etiology and
pathogenesis. Ann Intern Med 1972, 76:993-1008.
2. Fankhauser R, Monroe SS, Noel JS, Humohrey CD, Bresee JS, Parashar UD,
Ando T, Glass RI: Epidemiologic and molecular trends of “Norwalk-like
viruses” associated with outbreaks of gastroenteritis in the United
States. J Infect Dis 2002, 186:1-7.
3. Atmar RL, Estes MK: Diagnosis of noncultivatable gastroenteritis viruses,
the human caliciviruses. Clin Microbiol Rev 2001, 14:15-37.
4. Wang QH, Han MG, Cheetham S, Souza M, Funk JA, J L: Porcine Norivirus
Related to Human Noroviruses. Emerg Infect Dis 2005, 11(12):1874-81.
5. Kageyama T, Shinohara M, Uchida K, Fukushi S, Hoshino FB, Kojima S,
Takai R, Oka T, Takeda N, Katayama K: Coexistence of multiple genotypes,
including newly identified genotypes, in outbreaks of gastroenteritis
due to norovirus in Japan. J Clin Microbiol 2004, 42:2988-95.
6. Vinje J, Deijl H, van der Heide R, Lewis D, Hedlund KO, Svensson L,
Koopmans MP: Molecular detection and epidemiology of Sapporo-like
viruses. J Clin Microbiol 2000, 38:530-536.
7. Patel MM, Hall AJ, Vinjé J, Parashar UD: Noroviruses: a comprehensive
review. J Clin Virol 2009, 44:1-8.
8. Vinje J, Green J, Lewis DC, Gallimore CI, Brown DW, Koopmans MP: Genetic
polymorphism across regions of the three open reading frames of
Norwalk-like viruses. Arch Virol 2000, 145:223-241.
9. Lion T: Current recommendations for positive controls in RT-PCR assays.
Leukemia 2001, 15:1033-7.
10. Kaplan JE, Goodman RA, Schonberger LB, Lippy EC, Gary GW:
Gastroenteritis due to Norwalk virus: an outbreak associated with a
municipal water system. J Infect Dis 1982, 146:190-197.
11. Kaplan JE, Schonberger LB, Varano G, Jackman N, Bied J, Gary GW: An
outbreak of acute nonbacterial gastroenteritis in a nursing home:
demonstration of person-to-person transmission by temporal clustering
of cases. Am J Epidemiol 1982, 116:940-948.
12. Kaplan JE, Gary GW, Baron RC, Singh N, Schonberger LB, Feldman R,
Greenberg HB: Epidemiology of Norwalk gastroen-teritis and the role of
Norwalk virus in outbreaks of acute nonbacterial gastroenteritis. Ann
Intern Med 1982, 96:756-761.
13. Glass RI, Parashar UD, Estes MK: Norovirus gastroenteritis. N Engl J Med
2009, 361:1776-1785.
14. Hutson AM, Atmar RL, Estes MK: Norovirus disease: changing
epidemiology and host susceptibility factors. Trends Microbiol 2004,
12:279-287.
15. Kang JO, Kilgore P, Kim JS, Nyambat B, Kim J, Suh HS, Yoon YM, Jang SK,
Chang C, Choi S, Kim MN, Gentsch J, Bresee J, Glass R: Molecular
epidemiological profile of rotavirus in South Korea, July 2002 through
June 2003:emergence of G4P[6] and G9P[8] strains. J Infect Dis 2005,
192(Suppl 1):S57-63.
16. Atmar RL, Neill FH, Romalde JL, Le Guyader F, Woodley CM, Metcalf TG,
Estes MK: Detection of Norwalk virus and hepatitis A virus in shellfish
tissues with the PCR. Appl Environ Microbiol 1995, 61:3014-3018.
17. Schwab KJ, Schwab MK, Neill FH, Atmar RL: Use of heat release and an
internal RNA standard control in reverse transcription-PCR detection of
Norwalk virus from stool samples. J Clin Microbiol 1997, 35:511-514.
Figure 4 Detection of HRV and HAV using standardized
positive controls under the same RT-PCR conditions as clinical
and environmental samples. (A) Detection of HRV in clinical
sample: lane 1, HAV standardized positive; lane 2, clinical sample;
lane 3, negative control; lane 4, 100 bp ladder. (B) Detection of HAV
in environmental sample: lane 1, HAV standardized positive; lane 2,
environmental sample; lane 3, negative control; lane 4, negative
control; lane 5, 100 bp ladder.
Lee et al. Virology Journal 2011, 8:260
http://www.virologyj.com/content/8/1/260
Page 7 of 818. Yoon JS, Lee SG, Hong SK, Lee SA, Jheong WH, Oh SS, Oh MH, Ko GP,
Lee CH, Paik SY: Molecular Epidemiology of Norovirus Infections in
Children withAcute Gastroenteritis in South Korea in November 2005
through November 2006. J Clin Microbiol 2008, 46:1474-1477.
19. Kim HJ, Ko HA, Kim SH: Detection of Enteroviruses and Mammalian
Reoviruses by RT-PCR and Integrated Cell Culture-PCR in CPE-positive
Surface Water Samples. J Bacteriol Virol 2004, 34:331-338.
20. Lee KY, Jeong SJ, Seong HS, Kim KT, Hwang YS, Kim GY, Lee SH: Genetic
Analysis of Hepatitis A Virus Isolated from Korea. J Bacteriol Virol 2009,
39:165-171.
doi:10.1186/1743-422X-8-260
Cite this article as: Lee et al.: Standardized positive controls for
detection of norovirus by reverse transcription PCR. Virology Journal
2011 8:260.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Lee et al. Virology Journal 2011, 8:260
http://www.virologyj.com/content/8/1/260
Page 8 of 8